<DOC>
	<DOCNO>NCT00002220</DOCNO>
	<brief_summary>The purpose study compare effectiveness give indinavir plus efavirenz plus adefovir dipivoxil patient fail treatment nelfinavir patient never take protease inhibitor ( PI ) . Effectiveness measure number patient viral load ( level HIV blood ) 400 copies/ml 48 week treatment .</brief_summary>
	<brief_title>Indinavir Plus Efavirenz Plus Adefovir Dipivoxil HIV-Infected Patients Who Have Not Had Success With Nelfinavir</brief_title>
	<detailed_description>In open-label , nonrandomized study , 120 HIV-infected patient stratify two group : fail nelfinavir vs protease inhibitor-naive . All patient receive indinavir plus efavirenz plus adefovir dipivoxil plus L-carnitine , orally . Plasma vRNA measure every 4 week Week 16 , every 8 week remainder 48-week study .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Adefovir</mesh_term>
	<mesh_term>Adefovir dipivoxil</mesh_term>
	<mesh_term>Nelfinavir</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<mesh_term>Indinavir</mesh_term>
	<criteria>Inclusion Criteria Patients must : Serologically document HIV infection . Baseline CD4 count great equal 50 cell vRNA great equal 10,000 copies/ml . Parental consent patient 18 . NelfinavirFailure Group : Must protease inhibitor experience solely nelfinavir consider drugadherent . Must candidate change therapy virologic failure receive nelfinavir entry ( least 16 week nelfinavir plus NRTI therapy least 10fold decline vRNA due nelfinavir therapy subsequent increase toward patient 's baseline vRNA least 10fold ) . Control Group : Must receive combination currently license nucleoside reverse transcriptase inhibitor least 16 week . Must naive efavirenz , adefovir dipivoxil , NRTI 's . Exclusion Criteria Prior Medication : Excluded : Control group : Prior efavirenz , adefovir dipivoxil , nonnucleoside reverse transcriptase inhibitor . Required : Nelfinavirfailure patient : At least 16 week nelfinavir . Control group : At least 16 week combination currently license nucleoside reverse transcriptase inhibitor .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 1999</verification_date>
	<keyword>Drug Resistance</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Antiviral Agents</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
	<keyword>Indinavir</keyword>
	<keyword>RNA , Viral</keyword>
	<keyword>Adenine</keyword>
	<keyword>efavirenz</keyword>
</DOC>